# 119-s-3522: No Red Tape For Addiction Treatment Act

119-s-3522, No Red Tape For Addiction Treatment Act, is a 119th Congress bill sponsored by Sen. Hassan, Margaret Wood [D-NH] (D-NH); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-s-3522
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-3522
- Congress: 119
- Title: No Red Tape For Addiction Treatment Act
- Status: introduced
- Introduced: 2025-12-17
- Sponsor: Sen. Hassan, Margaret Wood [D-NH] (D-NH)
- Cosponsors: 1
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**This bill would require State Medicaid programs to cover at least one formulation of every medication and biological product for treating opioid use disorder without prior authorization or limits on dosage.** It would also require coverage of long‑acting injectable forms when available and would not stop States from keeping a formulary that meets existing federal rules. - People with opioid use disorder and their families would face fewer paperwork hurdles to start or continue medication‑assisted treatment because at least one form of each drug must be covered with no prior authorization and no dosage caps. - State Medicaid programs would need to change their plans or waivers to meet the new coverage rule. The requirement would apply to medical assistance provided on or after 1 year after enactment, and States that need new legislation get a limited implementation delay. - The Medicaid and CHIP Payment and Access Commission (MACPAC) would have to report to Congress within 1 year on how States use utilization management controls for medication‑assisted treatment, including dosing limits, age limits, counseling requirements, psychological screening, and the administrative burden on clinicians and providers.

## Cosponsors (1)

- Sen. Justice, James C. [R-WV] (R-WV), 2025-12-17T00:00:00.000Z

## Provisions PRIA read

- Easier Medicaid access to OUD medicines: benefit, medium. If enacted, this bill would require State Medicaid plans and waivers to cover at least one formulation of every drug or biological product used to treat opioid use disorder without prior authorization or dosage limits. If a long‑acting injectable form exists for a drug, the state would have to cove…

## Related bills

- 119-s-1748: Kids Online Safety Act
- 119-s-3265: Improve and Enhance the Work Opportunity Tax Credit Act
- 119-s-3990: PrEP Access and Coverage Act of 2026
- 119-s-1782: Charlotte Woodward Organ Transplant Discrimination Prevention Act
- 119-s-1241: Sanctioning Russia Act of 2025
- 119-s-847: Child Care Availability and Affordability Act

## Sources
- [119-s-3522 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/3522)

## Related
- [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748)
- [119-s-3265: Improve and Enhance the Work Opportunity Tax Credit Act](https://policyrisk.com/legislation/119-s-3265)
- [119-s-3990: PrEP Access and Coverage Act of 2026](https://policyrisk.com/legislation/119-s-3990)
- [119-s-1782: Charlotte Woodward Organ Transplant Discrimination Prevention Act](https://policyrisk.com/legislation/119-s-1782)
- [119-s-1241: Sanctioning Russia Act of 2025](https://policyrisk.com/legislation/119-s-1241)
- [119-s-847: Child Care Availability and Affordability Act](https://policyrisk.com/legislation/119-s-847)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-3522 (as of 2026-04-21).